Want to join the conversation?
$JNJ's Alios BioPharma said new data published in New England Journal of Medicine shows potential of compound to fight respiratory syncytial virus (RSV) infection. This Phase 2a study now established human proof-of-concept for antiviral activity of ALS-008176 in healthy adults and highlights potential as therapy for managing clinical disease.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?